14-52678444-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014584.3(ERO1A):c.347C>T(p.Ala116Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000645 in 1,612,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014584.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERO1A | NM_014584.3 | c.347C>T | p.Ala116Val | missense_variant | 4/16 | ENST00000395686.8 | NP_055399.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERO1A | ENST00000395686.8 | c.347C>T | p.Ala116Val | missense_variant | 4/16 | 1 | NM_014584.3 | ENSP00000379042 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152012Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000837 AC: 21AN: 250944Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135660
GnomAD4 exome AF: 0.0000685 AC: 100AN: 1460844Hom.: 0 Cov.: 29 AF XY: 0.0000647 AC XY: 47AN XY: 726796
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152012Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74258
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2024 | The c.347C>T (p.A116V) alteration is located in exon 4 (coding exon 4) of the ERO1A gene. This alteration results from a C to T substitution at nucleotide position 347, causing the alanine (A) at amino acid position 116 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at